Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine

NCT01084291 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NIH

Sponsor class

Conditions

Dengue Virus

Interventions

BIOLOGICAL: Investigational Vaccine for DEN1
OTHER: Placebo injection

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)